Details of the Drug

General Information of Drug (ID: DMUSGHP)

• Drug Name: Labetuzumab-SN-38

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 2	[1]

• Drug Type: Monoclonal antibody
• Cross-matching ID: TTD ID: D0E1ZV

References

• [1] Clinical pipeline report, company report or official report of Immunomedics.